• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001); Shock (2072)
Event Date 09/19/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Estimated age.Concomitant medical products: transseptal sheath.Mitraclip ntr clip delivery system.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the femoral vein perforation and hemorrhagic shock.It was reported that this was a mitraclip procedure to treat grade 3-4 functional mitral regurgitation (mr).On (b)(6) 2018, the steerable guide catheter (sgc) was inserted into the mildly tortuous, right femoral vein access site with difficulty.Two or three attempts were made to advance the sgc due to resistance with the femoral vein and the sgc was successfully advanced to the left atrium.The mitraclip ntr clip delivery system was inserted to the mitral valve and one mitraclip ntr was implanted.Post procedure mr grade was reduced to 1; however, the patient became unstable and was found to be in hemorrhagic shock.A perforation was found in the right femoral vein.On (b)(6) 2018 a covered stent was implanted, which successfully stopped the bleeding from the vein.The patient is in stable condition and the hospitalization was prolonged due to the injury.Either the sgc or the transseptal sheath was suspected to have caused the femoral vein perforation.No additional information was provided.
 
Manufacturer Narrative
Internal file number: (b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Review of the complaint history identified no similar incidents reported from this lot.The reported physical resistance while advancing the sgc (steerable guide catheter) was due to patient anatomy.The reported patient effect of perforation is likely due to the operational context as the physician possibly used extensive force while advancing the sgc or transseptal sheath.The reported hemorrhage and shock were cascading effects of the perforation.The hemorrhage, shock and vessel perforation, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.Based on the information reviewed, there is no indication of a product quality issue with respect to design, manufacturing, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8028446
MDR Text Key125792274
Report Number2024168-2018-08345
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 01/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/29/2019
Device Catalogue NumberSGC0302
Device Lot Number80628U123
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/12/2018
Initial Date FDA Received11/01/2018
Supplement Dates Manufacturer Received01/14/2019
Supplement Dates FDA Received01/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age77 YR
-
-